Cargando…

OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling

Obg-like ATPase 1 (OLA1) belongs to the Obg family of P-loop NTPases, and may serve as a “molecular switch” regulating multiple cellular processes. Aberrant expression of OLA1 has been observed in several human malignancies. However, the role of OLA1 in cancer progression remains poorly understood....

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Li, Yu, Zubin, Zhang, Jiawei, Yuan, Shuai, Liao, Chen, Jeyabal, Prince V.S, Rubio, Valentina, Chen, Huarong, Li, Yafei, Shi, Zheng-Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891128/
https://www.ncbi.nlm.nih.gov/pubmed/26863455
http://dx.doi.org/10.18632/oncotarget.7224
_version_ 1782435227921022976
author Bai, Li
Yu, Zubin
Zhang, Jiawei
Yuan, Shuai
Liao, Chen
Jeyabal, Prince V.S
Rubio, Valentina
Chen, Huarong
Li, Yafei
Shi, Zheng-Zheng
author_facet Bai, Li
Yu, Zubin
Zhang, Jiawei
Yuan, Shuai
Liao, Chen
Jeyabal, Prince V.S
Rubio, Valentina
Chen, Huarong
Li, Yafei
Shi, Zheng-Zheng
author_sort Bai, Li
collection PubMed
description Obg-like ATPase 1 (OLA1) belongs to the Obg family of P-loop NTPases, and may serve as a “molecular switch” regulating multiple cellular processes. Aberrant expression of OLA1 has been observed in several human malignancies. However, the role of OLA1 in cancer progression remains poorly understood. In this study, we used the Kaplan-Meier plotter search tool to show that increased expression of OLA1 mRNA was significantly associated with shorter overall survival in lung cancer patients. By immunohistochemical analysis we discovered that levels of OLA1 protein in lung cancer tissues were positively correlated with TNM stage and lymph node metastasis, but negatively correlated with the epithelial-mesenchymal transition (EMT) marker E-cadherin. Knockdown of OLA1 in a lung adenocarcinoma cell line rendered the cells more resistant to TGF- β-induced EMT and the accompanied repression of E-cadherin. Furthermore, our results demonstrated that OLA1 is a GSK3 β-interacting protein and inhibits GSK3 β activity by mediating its Ser9 phosphorylation. During EMT, OLA1 plays an important role in suppressing the GSK3 β-mediated degradation of Snail protein, which in turn promotes downregulation of E-cadherin. These data suggest that OLA1 contributes to EMT by modulating the GSK3 β/Snail/E-cadherin signaling, and its overexpression is associated with clinical progression and poor survival in lung cancer patients.
format Online
Article
Text
id pubmed-4891128
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-48911282016-06-23 OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling Bai, Li Yu, Zubin Zhang, Jiawei Yuan, Shuai Liao, Chen Jeyabal, Prince V.S Rubio, Valentina Chen, Huarong Li, Yafei Shi, Zheng-Zheng Oncotarget Research Paper Obg-like ATPase 1 (OLA1) belongs to the Obg family of P-loop NTPases, and may serve as a “molecular switch” regulating multiple cellular processes. Aberrant expression of OLA1 has been observed in several human malignancies. However, the role of OLA1 in cancer progression remains poorly understood. In this study, we used the Kaplan-Meier plotter search tool to show that increased expression of OLA1 mRNA was significantly associated with shorter overall survival in lung cancer patients. By immunohistochemical analysis we discovered that levels of OLA1 protein in lung cancer tissues were positively correlated with TNM stage and lymph node metastasis, but negatively correlated with the epithelial-mesenchymal transition (EMT) marker E-cadherin. Knockdown of OLA1 in a lung adenocarcinoma cell line rendered the cells more resistant to TGF- β-induced EMT and the accompanied repression of E-cadherin. Furthermore, our results demonstrated that OLA1 is a GSK3 β-interacting protein and inhibits GSK3 β activity by mediating its Ser9 phosphorylation. During EMT, OLA1 plays an important role in suppressing the GSK3 β-mediated degradation of Snail protein, which in turn promotes downregulation of E-cadherin. These data suggest that OLA1 contributes to EMT by modulating the GSK3 β/Snail/E-cadherin signaling, and its overexpression is associated with clinical progression and poor survival in lung cancer patients. Impact Journals LLC 2016-02-06 /pmc/articles/PMC4891128/ /pubmed/26863455 http://dx.doi.org/10.18632/oncotarget.7224 Text en Copyright: © 2016 Bai et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Bai, Li
Yu, Zubin
Zhang, Jiawei
Yuan, Shuai
Liao, Chen
Jeyabal, Prince V.S
Rubio, Valentina
Chen, Huarong
Li, Yafei
Shi, Zheng-Zheng
OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling
title OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling
title_full OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling
title_fullStr OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling
title_full_unstemmed OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling
title_short OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin signaling
title_sort ola1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the gsk3β/snail/e-cadherin signaling
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891128/
https://www.ncbi.nlm.nih.gov/pubmed/26863455
http://dx.doi.org/10.18632/oncotarget.7224
work_keys_str_mv AT baili ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT yuzubin ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT zhangjiawei ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT yuanshuai ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT liaochen ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT jeyabalprincevs ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT rubiovalentina ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT chenhuarong ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT liyafei ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling
AT shizhengzheng ola1contributestoepithelialmesenchymaltransitioninlungcancerbymodulatingthegsk3bsnailecadherinsignaling